Replies to post #165 on Novocure Ltd (NVCR)

[exwannabe]

NVCR is going to be a trading stock for a while. I do not see any likely positive/negative drivers within the next year.

There is the IA in the ovarian trial in the next month or two. But that is so early that it is 90% to be the blah "trials continues as planned".

I doubt any real excitement on the operation/financial side. Hopefully a bit more uptick than the last set of numbers.

So, play your charts to your hearts content :-)